5.7% Yielding AbbVie Represents One Of The Fattest Pitches On Wall Street Today

  • AbbVie, one of the highest-quality dividend aristocrats, has been falling steadily for weeks, for no fundamental reason.
  • So let’s take a look at the six reasons that 5.7% yielding AbbVie is potentially one of the best high-yield dividend aristocrats for prudent income investors.
  • AbbVie is one of the most reasonable and prudent high-yield blue-chips conservative income investors can buy in this overvalued market.
  • Looking for a helping hand in the market? Members of iREIT on Alpha get exclusive ideas and guidance to navigate any climate. Get started today »

This article was coproduced with Dividend Sensei.

Warren Buffett famously talked about how he likes to wait for “fat pitches”:

“I call investing the greatest business in the world because you never have to swing. You stand at the plate, the pitcher throws you General Motors at 47! U.S. Steel at 39! And nobody calls a strike on you. There’s no penalty except opportunity lost. All day, you wait for the pitch you like. Then, when the fielders are asleep, you step up and hit it…

“Wait for a fat pitch and then swing for the fences.”

Wall Street is fixated on the stimulus negotiations, which aren’t progressing. Economists expect no deal until early next year.

At last check, the S&P 500 was still 33% historically overvalued. That’s about 4% within its all-time high, making a lot of the markets’ pitches less than advisable to try connecting with.

However, AbbVie ( ABBV) is a very high-quality dividend aristocrat that’s been falling steadily for weeks – for no fundamental reason.

This creates the opportunity for prudent long-term income growth investors to lock in not just a safe 5.7% yield, but also some of the best long-term return potential Wall Street has to offer.

How confident are we in recommending pharmaceutical juggernaut AbbVie right now?